Which nerve block cuts opioid use after lung cancer surgery?
NCT ID NCT07040618
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two ultrasound-guided nerve blocks—rhomboid intercostal block and erector spinae plane block—for pain control after lung cancer surgery. Sixty adults undergoing thoracotomy will receive one of the two blocks with bupivacaine. Researchers will measure morphine use, pain scores, and recovery over 24 hours to see which block works better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bupivacaine
- What this could lead to
- If one block works better, it could mean less morphine and faster recovery after lung cancer surgery.
- What could go wrong
- This is a small, early-stage trial (60 people) comparing two established techniques. It may not show a clear winner, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Institute - Cairo University
RECRUITINGCairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection